Prognostic significance of non-HPV16 genotypes in oropharyngeal squamous cell carcinoma

Highlights • First to study the prognostic significance of non-HPV16 genotypes with p16 status. • HPV16-positve oropharynx tumors have better survival than non-HPV16-positive genotypes. • The survival benefit for HPV16-positve genotypes holds for tumors positive for p16, but not for p16-negative tum...

Full description

Saved in:
Bibliographic Details
Published inOral oncology Vol. 61; pp. 98 - 103
Main Authors Mazul, Angela L., PhD, MPH, Rodriguez-Ormaza, Nidia, MD, MPH, Taylor, James M., MPH, Desai, Dipan D, Brennan, Paul, PhD, MS, Anantharaman, Devasena, PhD, MSc, Gheit, Tarik, PhD, Tommasino, Massimo, PhD, Abedi-Ardekani, Behnoush, MD, Olshan, Andrew F., PhD, MS, Zevallos, Jose P., MD, MPH
Format Journal Article
LanguageEnglish
Published England Elsevier Ltd 01.10.2016
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Highlights • First to study the prognostic significance of non-HPV16 genotypes with p16 status. • HPV16-positve oropharynx tumors have better survival than non-HPV16-positive genotypes. • The survival benefit for HPV16-positve genotypes holds for tumors positive for p16, but not for p16-negative tumors.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:1368-8375
1879-0593
DOI:10.1016/j.oraloncology.2016.08.019